AVRW.US Avenir Wellness Solutions Inc.
- Market cap
- USD 16.6K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is AVRW.US undervalued?
Graham numberThe Graham number of Avenir Wellness Solutions Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Avenir Wellness Solutions Inc. fundamental analysis
No fundamental analysis for Avenir Wellness Solutions Inc. yet.
Avenir Wellness Solutions Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Avenir Wellness Solutions Inc.
Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as…
Full company profileAvenir Wellness Solutions Inc. financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Avenir Wellness Solutions Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 623K | 2.05M | 6.08M | 4.90M | 4.35M | 1.23M |
| Gross Profit | 392K | 975K | 4.33M | 3.34M | 3.11M | 976K |
| Operating Income | -1.73M | -19.0M | -10.4M | -18.3M | -5.51M | -2.79M |
| EBITDA | -16.6M | -27.2M | -5.53M | -16.5M | -3.20M | -3.46M |
| Net Income | -21.4M | -30.6M | -13.2M | -25.5M | -3.44M | -3.64M |
| EPS | -0.45 | -0.65 | -0.21 | -0.36 | -0.05 | -0.05 |
| Balance Sheet | ||||||
| Total Assets | 32.5M | 46.4M | 40.6M | 6.85M | 2.61M | 748K |
| Total Liabilities | 16.1M | 25.1M | 24.5M | 14.0M | 12.5M | 13.3M |
| Shareholders' Equity | 13.5M | 21.3M | 16.1M | -7.11M | -9.89M | -12.5M |
| Cash & Short-term Investments | 4.10M | 1.73M | 16.0K | 2.94M | 49.0K | 11.0K |
| Total Debt | 790K | 16.3M | 13.9M | 10.1M | 8.28M | 8.86M |
| Cash Flow | ||||||
| Operating Cash Flow | -8.10M | -9.72M | -4.32M | -10.1M | -3.84M | -1.36M |
| Capital Expenditure | 408K | 688K | 118K | 1.00K | 54.0K | 1.33K |
| Free Cash Flow | -8.51M | -10.4M | -4.43M | -10.1M | -3.90M | -1.36M |
| Ratios | ||||||
| ROE | -158.2% | -143.9% | -81.9% | - | - | - |
| ROA | -65.8% | -66.1% | -32.5% | -372.2% | -132.1% | -487.2% |
| Net Profit Margin | -3,429.1% | -1,493.0% | -217.1% | -521.0% | -79.2% | -297.4% |
| Debt to Equity | 0.06x | 0.77x | 0.86x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Avenir Wellness Solutions Inc. dividends
Avenir Wellness Solutions Inc. has not paid dividends in the last 5 fiscal years.
Last stock split: 3.6:1 on Jul 21, 2016.
Who owns Avenir Wellness Solutions Inc.
- Insiders 0.00%
- Institutions 10.65%
- Public & others 89.35%
- Shares outstanding 83.1M
- Free float 71.7M
Avenir Wellness Solutions Inc. company profile
- Company name
- Avenir Wellness Solutions Inc.
- Ticker
- AVRW.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 15233 Ventura Boulevard, Sherman Oaks, CA, United States, 91403
- Phone
- 424 273 8675
- Website
- avenirwellness.com
About Avenir Wellness Solutions Inc.
Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as well as online and in-store at national drug, mass retailers, grocery chains, convenience stores, and on Amazon.com. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is based in Sherman Oaks, California.
Avenir Wellness Solutions Inc. management
7- Mr. Robert DavidsonFounder, Chief Scientist & Chairman of the Board · born 1967
- Mr. Joel M. Bennett CPACFO, Chief Accounting Officer, Secretary, Treasurer & Interim CEO · born 1962
- Ms. Patricia HessChief Operating Officer
- Mr. Bhaumik PatelDirector of New Technologies
- Mr. John Cammarano Jr.Senior Vice President of Sales · born 1964
- Dr. Rahul Dixit M.D.Chief Medical Officer & Member of Medical Advisory Board
- Mr. Rick PetrySenior VP & Executive Creative Director